Calcium Ionophore A23187, > = 98% ( TLC), poudre

Code: c7522-5mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Calcium ionophore A23187 has been used: as an endoplasmic reticulum (ER) stress inducer to study its effect on the expression of the toxoplasma unfolded protein r...


en savoir plus

Votre prix
£149.00 5MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Calcium ionophore A23187 has been used: as an endoplasmic reticulum (ER) stress inducer to study its effect on the expression of the toxoplasma unfolded protein response (UPR) genes for the induction of the acrosome reaction in skeletal muscle sarcoplasmic reticulum Ca2+ ATPase (SERCA) activity assay

Ionophore highly selective for Ca2+. Potentiates responses to NMDA but not quisqualate. In cell culture, stimulates nitric oxide production by calmodulin-dependent constitutive nitric oxide synthase.

Biochem/physiol Actions

Calcium ionophore A23187 is a carboxylic acid antibiotic with weak in vitro activity against Gram-positive organisms. It increases the potential of divalent ions to cross biological membranes, thus it acts as an ionophore. Calcium ionophore A23187 specifically forms stable 2:1 complexes with divalent cations, rendering these ions soluble in ordinary organic solvents. Since calcium ionophore A23187 is commonly used to increase intracellular Ca2+ levels in intact cells, it acts as an uncoupler of oxidative phosphorylation and an inhibitor of mitochondrial adenosine triphosphatase (ATPase) activity. Calcium Ionophore A23187 is a potent inducer of phosphorylation of Toxoplasma eukaryotic initiation factor-2α (eIF2α). It also induces apoptosis in mouse lymphoma cell line (S49)7 but also has been shown to block apoptosis in other systems, such as when interleukin-3 (IL-3) is withdrawn from IL-3-dependent cells.

Packaging

1, 5, 10 mg in serum bottle

antibiotic activity spectrumfungi, Gram-positive bacteria
assay≥98% (TLC)
colorwhite to light yellow
formpowder
InChI keyHIYAVKIYRIFSCZ-CYEMHPAKSA-N
InChI1S/C29H37N3O6/c1-15-10-11-29(17(3)13-16(2)27(38-29)18(4)26(33)20-7-6-12-31-20)37-22(15)14-23-32-25-21(36-23)9-8-19(30-5)24(25)28(34)35/h6-9,12,15-18,22,27,30-31H,10-11,13-14H2,1-5H3,(H,34,35)/t15-,16-,17-,18-,22-,27+,29+/m1/s1
mode of actioncell membrane | interferes
Quality Level300
SMILES string[H][C@@]1(O[C@@]2(CC[C@@H](C)[C@@H](Cc3nc4c(C(O)=O)c(NC)ccc4o3)O2)[C@H](C)C[C@H]1C)[C@H](C)C(=O)c5ccc[nH]5
solubilityethanol: 5 mg/mL (with heating. Solutions are stable for at least 3 months at -20 °C when protected from light and water contamination.), DMSO: 50 mg/mL (with heating or sonication. Solutions are stable for at least 3 months at -20 °C when protected from light and water contamination.)
sterilitynon-sterile
storage temp.2-8°C
Code
Description
Unité de vente
Prix annoncé
Qté
C7522-10MG
Unité:10MG
Prix annoncé: £272.00
Source:Prix annoncé
C7522-1MG
Unité:1MG
Prix annoncé: £55.90
Source:Prix annoncé
C7522-50MG
Unité:50MG
Prix annoncé: £505.00
Source:Prix annoncé
Cas Number52665-69-7
Ce produit répond aux critères suivants: